1. Home
  2. CYTH vs JRSH Comparison

CYTH vs JRSH Comparison

Compare CYTH & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • JRSH
  • Stock Information
  • Founded
  • CYTH 1990
  • JRSH 2016
  • Country
  • CYTH United States
  • JRSH United States
  • Employees
  • CYTH N/A
  • JRSH N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • JRSH Apparel
  • Sector
  • CYTH Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • CYTH Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • CYTH 35.5M
  • JRSH 37.6M
  • IPO Year
  • CYTH N/A
  • JRSH 2018
  • Fundamental
  • Price
  • CYTH $1.21
  • JRSH $2.97
  • Analyst Decision
  • CYTH Strong Buy
  • JRSH
  • Analyst Count
  • CYTH 3
  • JRSH 0
  • Target Price
  • CYTH $3.20
  • JRSH N/A
  • AVG Volume (30 Days)
  • CYTH 27.5K
  • JRSH 10.8K
  • Earning Date
  • CYTH 08-12-2024
  • JRSH 08-07-2024
  • Dividend Yield
  • CYTH N/A
  • JRSH 6.67%
  • EPS Growth
  • CYTH N/A
  • JRSH N/A
  • EPS
  • CYTH N/A
  • JRSH N/A
  • Revenue
  • CYTH $1,126,444.00
  • JRSH $117,187,340.00
  • Revenue This Year
  • CYTH $28.30
  • JRSH $10.72
  • Revenue Next Year
  • CYTH $14.19
  • JRSH $12.10
  • P/E Ratio
  • CYTH N/A
  • JRSH N/A
  • Revenue Growth
  • CYTH N/A
  • JRSH N/A
  • 52 Week Low
  • CYTH $0.89
  • JRSH $2.77
  • 52 Week High
  • CYTH $2.12
  • JRSH $3.97
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 44.17
  • JRSH 51.35
  • Support Level
  • CYTH $1.13
  • JRSH $2.97
  • Resistance Level
  • CYTH $1.28
  • JRSH $2.98
  • Average True Range (ATR)
  • CYTH 0.08
  • JRSH 0.07
  • MACD
  • CYTH -0.00
  • JRSH 0.01
  • Stochastic Oscillator
  • CYTH 16.67
  • JRSH 60.00

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants and shorts made from knitted fabric.

Share on Social Networks: